Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Hayman

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Haematologica|December 7, 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trialDavid Dingli, S Vincent Rajkumar, Grzegorz S Nowakowski, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Bone Marrow Transplantation|December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Bone Marrow Transplantation|November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosisIuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Leukemia|March 5, 2025
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myelomaSarah Dingli, Paul Rothweiler, Moritz Binder, et al.
Haematologica|December 7, 2005
Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trialDavid Dingli, S Vincent Rajkumar, Grzegorz S Nowakowski, et al.
Leukemia & Lymphoma|October 29, 2020
Retroperitoneal involvement with light chain amyloidosis- case series and literature reviewIuliana Vaxman, Alissa Visram, Oren Pasvolsky, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2021
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell LeukemiaRicardo D Parrondo, Muhamad Alhaj Moustafa, Craig Reeder, et al.
Transplantation and Cellular Therapy|April 10, 2021
Prognostic Implications of Rising Serum Monoclonal Protein and Free Light Chains after Autologous Stem Cell Transplantation in Patients with Multiple MyelomaHarsh Parmar, Abdullah S Al Saleh, Alissa Visram, et al.
British Journal of Haematology|November 29, 2024
Autologous stem cell transplantation for multiple myeloma patients whose myeloma-defining event was SLiMIuliana Vaxman, Shaji Kumar, Inbar Cohen, et al.
Research Square|November 14, 2023
Mode of Progression in Smoldering Multiple Myeloma: A study of 406 patientsS Rajkumar, Nadine Abdallah, Arjun Lakshman, et al.
Bone Marrow Transplantation|December 4, 2020
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agentsIuliana Vaxman, Alissa Visram, Shaji Kumar, et al.
Bone Marrow Transplantation|November 19, 2020
Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosisIuliana Vaxman, M Hasib Sidiqi, Abdullah S Al Saleh, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Pageof 8